SCHEMBL6960015

SCHEMBL6960015

Cc1cccc(C)c1-c1cc(O)c(SCc2ccccc2)c(=O)o1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 4/20 0.44
EGFR P00533 2/20 0.39
DAO P14920 3/20 0.39
FFAR1 O14842 1/20 0.37
NPC1 O15118 1/20 0.37
HPGD P15428 1/20 0.37
MAPK1 P28482 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA7 P43166 1/20 0.36
CA13 Q8N1Q1 1/20 0.36
S100A4 P26447 1/20 0.36
CNR2 P34972 1/20 0.36
GPR55 Q9Y2T6 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6954431 0.91 EGFR (0.40) ELANEEGFRDAONPC1HPGD
SCHEMBL6958994 0.88 HPGD (0.45) ELANEEGFRDAONPC1HPGD
SCHEMBL6964669 0.84 ELANE (0.39) ELANEEGFRDAONPC1HPGD
SCHEMBL6953390 0.83 SMN1; SMN2 (0.49) ELANEEGFRDAONPC1HPGD
SCHEMBL6954786 0.83 SMN1; SMN2 (0.50) ELANEDAOHPGDMAPK1SMN1; SMN2
SCHEMBL6963460 0.82 EGFR (0.41) ELANEEGFRDAONPC1HPGD
SCHEMBL6963367 0.82 POLB (0.45) EGFRDAONPC1HPGDRAB9A
SCHEMBL11788874 0.81 DAO (0.43) ELANEEGFRDAOSMN1; SMN2ALDH1A1
SCHEMBL6956094 0.81 AKR1C3 (0.46) ELANEEGFRDAOHPGDMAPK1
SCHEMBL6965958 0.81 ELANE (0.40) ELANEEGFRMAPK1SMN1; SMN2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0729465-B1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2003-01-22 EP disclosed
US-6005103-A TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS WARNER-LAMBERT COMPANY (US) 1999-12-21 US disclosed
US-5808062-A AIDS THERAPY WARNER-LAMBERT COMPANY (US) 1998-09-15 US disclosed
EP-0729465-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
WO-1995014013-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed